Loading
Latest filing published 05 Jun 2025 for 60 DEGREES PHARMACEUTICALS, INC., €7,563. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Cheryl Xu on record concern 60 Degrees Pharmaceuticals, Inc. Between 31 January 2024 and 3 June 2025, the trades on record add up to 5 filings.
Every open-market trade on record is a purchase: 4 purchases worth €89k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 option exercise. So far in 2025, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €7,584. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 5 June 2025, reports an open-market purchase of €7,563 in 60 Degrees Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations